samedan logo
 
 
 
spacer
home > pmps > summer 2008 > dosage dilemmas
PAY PER VIEW SERVICE

 

Dear guest!

article: Dosage Dilemmas
format: Adobe Acrobat PDF file
cost: £

spacer

 
News and Press Releases

Vectura signs agreement with Kinaset Therapeutics Inc. to support the development of VR588 to treat asthma

Chippenham, UK 30 November 2020: Vectura Group plc, an industry leading inhalation CDMO, today announces that it has signed a global out licence and development agreement with Kinaset Therapeutics Inc. for the development and commercialisation of VR588, a preclinical novel inhaled pan-JAK inhibitor for the prevention and treatment of severe asthma.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement